Prima BioMed (IMMP)
(Delayed Data from NSDQ)
$1.75 USD
-0.03 (-1.69%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.78 +0.03 (1.71%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Prima BioMed Ltd has a market cap of $261.28M, which represents its share price of $1.78 multiplied by its outstanding shares number of 146.79M. As a small-cap company, IMMP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IMMP 1.75 -0.03(-1.69%)
Will IMMP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMMP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for IMMP
Immutep (IMMP) Receives FDA Support for Cancer Drug Development
Immutep receives FDA feedback on clinical development of eftilagimod alfa
Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod ...
Immutep (IMMP) Demonstrates Robust Financial Management Amid Clinical Trials
Immutep reports Q4 cash receipts from customers A$6,000